Treatment of relapsing mild - to -
moderate ulcerative colitis with the probiotic VSL # 3 as adjunctive to a standard pharmaceutical treatment: a double - blind, randomized, placebo - controlled study.
On page 2 of the 3 page document, in bold type it states: «The bottom line, says Dr. Dieleman, is that probiotic / prebiotic therapies have shown to be beneficial for mild to
moderate ulcerative colitis when used in combination with standard pharmaceutical therapies under medical supervision.»
Tursi A et al; Low - Dose Balsalazide Plus a High - Potency Probiotic Preparation is More Effective than Balsalazide Alone or Mesalazine in the Treatment of Acute Mild - to -
Moderate Ulcerative Colitis; Med Sci; 2004 Nov; 10 (11): PI126 - 31.
Not exact matches
Attachment insecurity
moderates the relationship between disease activity and depressive symptoms in
ulcerative colitis.